29 January 2020
Sale of Minority Share in Scienta Omicron
Oxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, today announces that it has completed the sale of its 47% share in Scienta Omicron to a group of existing shareholders in the joint venture for a consideration of SEK 147 million (£11.7 million).
The joint venture was established in 2015 consisting of Oxford Instruments’ Omicron Nanotechnology GmBH and GDI’s Scienta Scientific, creating a leading company in Ultra High Vacuum Surface Science.
Ian Barkshire, Chief Executive of Oxford Instruments said, “The sale of our share in Scienta Omicron supports our continued customer-centric focus on our chosen markets with long-term growth drivers where we can maintain or develop leading positions, enhancing our ability to deliver further growth and margin improvement.”